UG Healthcare Corporation Statistics

Total Valuation

SGXC:8K7 has a market cap or net worth of SGD 74.86 million. The enterprise value is 94.27 million.

Market Cap	74.86M
Enterprise Value	94.27M

Important Dates

The last earnings date was Monday, February 10, 2025.

Earnings Date	Feb 10, 2025
Ex-Dividend Date	n/a

Share Statistics

SGXC:8K7 has 623.83 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	623.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.46%
Owned by Institutions (%)	1.69%
Float	187.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.54
PB Ratio	0.46
P/TBV Ratio	0.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.41, with an EV/FCF ratio of -7.62.

EV / Earnings	-46.83
EV / Sales	0.68
EV / EBITDA	24.41
EV / EBIT	n/a
EV / FCF	-7.62

Financial Position

The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.28.

Current Ratio	3.32
Quick Ratio	1.83
Debt / Equity	0.28
Debt / EBITDA	11.42
Debt / FCF	-3.62
Interest Coverage	0.20

Financial Efficiency

Return on equity (ROE) is -2.93% and return on invested capital (ROIC) is 0.11%.

Return on Equity (ROE)	-2.93%
Return on Assets (ROA)	0.10%
Return on Invested Capital (ROIC)	0.11%
Return on Capital Employed (ROCE)	0.19%
Revenue Per Employee	153,867
Profits Per Employee	-2,242
Employee Count	898
Asset Turnover	0.62
Inventory Turnover	1.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.03% in the last 52 weeks. The beta is 1.00, so SGXC:8K7's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-7.03%
50-Day Moving Average	0.12
200-Day Moving Average	0.12
Relative Strength Index (RSI)	48.12
Average Volume (20 Days)	140,575

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:8K7 had revenue of SGD 138.17 million and -2.01 million in losses. Loss per share was -0.00.

Revenue	138.17M
Gross Profit	36.58M
Operating Income	354,000
Pretax Income	-4.18M
Net Income	-2.01M
EBITDA	3.23M
EBIT	354,000
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 22.22 million in cash and 44.75 million in debt, giving a net cash position of -22.53 million or -0.04 per share.

Cash & Cash Equivalents	22.22M
Total Debt	44.75M
Net Cash	-22.53M
Net Cash Per Share	-0.04
Equity (Book Value)	160.35M
Book Value Per Share	0.26
Working Capital	104.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.77 million and capital expenditures -2.60 million, giving a free cash flow of -12.38 million.

Operating Cash Flow	-9.77M
Capital Expenditures	-2.60M
Free Cash Flow	-12.38M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 26.47%, with operating and profit margins of 0.26% and -1.46%.

Gross Margin	26.47%
Operating Margin	0.26%
Pretax Margin	-3.02%
Profit Margin	-1.46%
EBITDA Margin	2.33%
EBIT Margin	0.26%
FCF Margin	n/a

Dividends & Yields

SGXC:8K7 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.69%
FCF Yield	-16.53%

Dividend Details

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 3.

Last Split Date	Sep 30, 2020
Split Type	Forward
Split Ratio	3

Scores

SGXC:8K7 has an Altman Z-Score of 2.84. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.84
Piotroski F-Score	n/a